Filing Details
- Accession Number:
- 0000939767-17-000038
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-17 19:51:50
- Reporting Period:
- 2017-03-15
- Filing Date:
- 2017-03-17
- Accepted Time:
- 2017-03-17 19:51:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 939767 | Exelixis Inc. | EXEL | Services-Commercial Physical & Biological Research (8731) | 043257395 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1213140 | Gisela Schwab | C/O Exelixis, Inc. 210 E. Grand Ave. South San Francisco CA 94080 | Pres Prod Dev & Med Aff & Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-03-15 | 17,707 | $4.42 | 175,760 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-03-15 | 32,300 | $7.18 | 208,060 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-03-15 | 50,007 | $22.53 | 158,053 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (right to buy) | Disposition | 2017-03-15 | 17,707 | $0.00 | 17,707 | $4.42 |
| Common Stock | Option (right to buy) | Disposition | 2017-03-15 | 32,300 | $0.00 | 32,300 | $7.18 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,293 | 2010-02-26 | 2019-02-25 | No | 4 | M | Direct |
| 177,700 | 2010-12-09 | 2019-12-08 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 13,974 | Indirect | By 401(k) |
Footnotes
- Includes 20,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- Represents 13,974 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of March 15, 2017.
- The option, representing the right to purchase a total of 25,000 shares of Exelixis, Inc. common stock, became fully exercisable on February 26, 2013.
- The option, representing the right to purchase a total of 210,000 shares of Exelixis, Inc. common stock, became fully exercisable on December 9, 2013.
Billionaire Hedge Funds
